Otonomy (NASDAQ:OTIC) Receives New Coverage From Analysts at StockNews.com
Otonomy (NASDAQ:OTIC) Receives New Coverage From Analysts at StockNews.com
Investment analysts at StockNews.com started coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research note issued on Thursday. The brokerage set a "hold" rating on the biopharmaceutical company's stock.
StockNews.com的投资分析师开始报道以下股票 Otonomy（纳斯达克股票代码：OTIC — 获取评级） 在周四发布的研究报告中。该经纪公司对这家生物制药公司的股票设定了 “持有” 评级。
Separately, Piper Sandler cut Otonomy from an "overweight" rating to a "neutral" rating and dropped their price target for the stock from $3.00 to $0.50 in a research report on Thursday, October 13th.
另外，派珀·桑德勒在10月13日星期四的一份研究报告中将Otonomy从 “增持” 评级下调至 “中性” 评级，并将该股的目标股价从3.00美元下调至0.50美元。
Otonomy Stock Down 7.5 %
Otonomy 股票下跌 7.5 ％
Shares of NASDAQ OTIC opened at $0.11 on Thursday. The stock's 50 day moving average price is $0.11 and its two-hundred day moving average price is $0.32. Otonomy has a 52-week low of $0.06 and a 52-week high of $2.59. The stock has a market capitalization of $6.84 million, a P/E ratio of -0.14 and a beta of 1.47.
纳斯达克OTIC的股票周四开盘价为0.11美元。该股的50天移动平均线价格为0.11美元，其两百天移动平均线价格为0.32美元。Otonomy创下52周低点0.06美元，52周高点为2.59美元。该股的市值为684万美元，市盈率为-0.14，beta值为1.47。
Institutional Trading of Otonomy
自主学的机构交易
Several large investors have recently added to or reduced their stakes in OTIC. Dimensional Fund Advisors LP increased its position in Otonomy by 17.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 841,694 shares of the biopharmaceutical company's stock valued at $2,020,000 after acquiring an additional 126,747 shares during the period. Silverarc Capital Management LLC boosted its stake in shares of Otonomy by 0.6% during the 1st quarter. Silverarc Capital Management LLC now owns 1,207,385 shares of the biopharmaceutical company's stock worth $2,898,000 after acquiring an additional 7,571 shares in the last quarter. State Street Corp boosted its stake in shares of Otonomy by 5.1% during the 1st quarter. State Street Corp now owns 182,239 shares of the biopharmaceutical company's stock worth $437,000 after acquiring an additional 8,839 shares in the last quarter. Point72 Asset Management L.P. acquired a new stake in shares of Otonomy in the third quarter worth $1,621,000. Finally, Lynx1 Capital Management LP raised its holdings in shares of Otonomy by 7,609.6% during the third quarter. Lynx1 Capital Management LP now owns 2,312,880 shares of the biopharmaceutical company's stock worth $682,000 after acquiring an additional 2,282,880 shares in the last quarter. 41.23% of the stock is currently owned by institutional investors and hedge funds.
几位大型投资者最近增加了或减少了在OTIC的股份。Dimension Fund Advisors LP在第一季度将其在Otonomy的头寸增加了17.7％。在此期间又收购了126,747股股票后，Dimension Fund Advisors LP现在拥有这家生物制药公司的841,694股股票，价值202万美元。Silverarc Capital Management LLC在第一季度将其在Otonomy的股份增加了0.6％。Silverarc Capital Management LLC在上个季度又收购了7,571股股票后，现在拥有这家生物制药公司的1,207,385股股票，价值289.8万美元。State Street Corp在第一季度将其在Otonomy的股份增加了5.1％。State Street Corp在上个季度又收购了8,839股股票后，现在拥有这家生物制药公司的182,239股股票，价值43.7万美元。Point72 Asset Management L.P. 在第三季度收购了价值16.1万美元的Otonomy股票的新股份。最后，Lynx1 Capital Management LP在第三季度将其持有的Otonomy股票提高了7,609.6％。Lynx1 Capital Management LP在上个季度又收购了2,282,880股股票后，现在拥有这家生物制药公司的2312,880股股票，价值68.2万美元。该股票的41.23％目前由机构投资者和对冲基金持有。
About Otonomy
关于自主学
(Get Rating)
（获取评分）
Otonomy, Inc operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm's product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss.
Otonomy, Inc是一家生物制药公司。从事神经病学疗法的开发。该公司的产品线包括OTIVIDEX（地塞米松）梅尼尔病、OTIPRIO（环丙沙星视力悬浮液）急性带管中耳炎（AOMT）、OTO-313（加环素）耳鸣、OTO-413（BDNF）隐性听力损失、OTO-510（耳保护剂）预防CIHL、OTO-6XX（毛细胞再生）严重听力损失。
Further Reading
进一步阅读
- Get a free copy of the StockNews.com research report on Otonomy (OTIC)
- Bed Bath & Beyond Is Circling the Drain
- Allegro Microsystems Is A Well-Positioned Semiconductor Stock
- Scotts Miracle-Gro Hits Bottom, Reversal In Play
- Altria is a Great Recession Stock, Long-Term Outlook Uncertain
- Novavax Shares Jumped in January While Others Slipped
- 免费获取 StockNews.com 关于自主学的研究报告（OTIC）的副本
- Bed Bath & Beyond 正在排水管中盘旋
- Allegro Microsystems 是一家定位良好的半导体
- Scotts Miracle-Gro 触底，在比赛中逆转
- 奥驰亚是大萧条股票，长期前景不确定
- Novavax股价在1月份上涨，而其他股则下滑
Receive News & Ratings for Otonomy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otonomy and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Otonomy Daily 的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Otonomy及相关公司的最新新闻和分析师评级的简明每日摘要。
译文内容由第三方软件翻译。